212 related articles for article (PubMed ID: 33494881)
21. Hemolytic disease of the fetus and newborn: systematic literature review of the antenatal landscape.
de Winter DP; Kaminski A; Tjoa ML; Oepkes D
BMC Pregnancy Childbirth; 2023 Jan; 23(1):12. PubMed ID: 36611144
[TBL] [Abstract][Full Text] [Related]
22. Postnatal outcome in neonates with severe Rhesus c compared to rhesus D hemolytic disease.
Rath ME; Smits-Wintjens VE; Lindenburg IT; Folman CC; Brand A; van Kamp IL; Oepkes D; Walther FJ; Lopriore E
Transfusion; 2013 Jul; 53(7):1580-5. PubMed ID: 23113703
[TBL] [Abstract][Full Text] [Related]
23. Serologic reactivity of unidentified specificity in antenatal testing and hemolytic disease of the fetus and newborn: The BEST collaborative study.
Lu W; Ziman A; Yan MTS; Waters A; Virk MS; Tran A; Tang H; Shih AW; Scally E; Raval JS; Pandey S; Pagano MB; Shan H; Moore C; Morrison D; Cormack O; Fitzgerald J; Duncan J; Corean J; Clarke G; Yazer M
Transfusion; 2023 Apr; 63(4):817-825. PubMed ID: 36815517
[TBL] [Abstract][Full Text] [Related]
24. Third trimester screening for alloimmunisation in Rhc-negative pregnant women: evaluation of the Dutch national screening programme.
Slootweg YM; Koelewijn JM; van Kamp IL; van der Bom JG; Oepkes D; de Haas M
BJOG; 2016 May; 123(6):955-63. PubMed ID: 26661943
[TBL] [Abstract][Full Text] [Related]
25. The prenatal intervention of pregnancy complicated with anti-Kell isoimmunization: a review.
Sun JB
J Matern Fetal Neonatal Med; 2021 Sep; 34(17):2893-2899. PubMed ID: 31571493
[TBL] [Abstract][Full Text] [Related]
26. Low titer group O whole blood and risk of RhD alloimmunization: Rationale for use in Finland.
Susila S; Ilmakunnas M; Lauronen J; Vuorinen P; Ångerman S; Sainio S
Transfusion; 2024 May; 64 Suppl 2():S119-S125. PubMed ID: 38240146
[TBL] [Abstract][Full Text] [Related]
27. Hemolytic disease of the fetus and newborn mediated by anti-Di
Jacobs JW; Abels E; Binns TC; Tormey CA; Sostin N
Immunohematology; 2023 Apr; 39(1):32-34. PubMed ID: 37017601
[TBL] [Abstract][Full Text] [Related]
28. Maternal Cold-Reacting Immunoglobulin G Anti-M of MNS Blood Group System Causing Hemolytic Disease of the Fetus.
Liang YL; Shi Y; Su YQ; Wu F; Liang Y; Fan X; Lin J; Liu Y; Long P; Ren J; Liang S
Iran J Immunol; 2023 Mar; 20(1):129-134. PubMed ID: 36934323
[TBL] [Abstract][Full Text] [Related]
29. Anemic Disease of the Newborn With Little Increase in Hemolysis and Erythropoiesis Due to Maternal Anti-Jr
Katsuragi S; Ohto H; Yoshida A; Otake A; Tsuneyama H; Ogasawara K; Isa K; Ikeda T
Transfus Med Rev; 2019 Jul; 33(3):183-188. PubMed ID: 31227265
[TBL] [Abstract][Full Text] [Related]
30. Severe hemolytic disease of the fetus and newborn due to allo-anti-D in a patient with a partial DEL phenotype arising from the variant allele described as RHD*148+1T (RHD*01EL.31).
Turley E; McGowan EC; Hyland CA; Schoeman EM; Flower RL; Skoll A; Delisle MF; Nelson T; Clarke G; Au N
Transfusion; 2018 Oct; 58(10):2260-2264. PubMed ID: 30222865
[TBL] [Abstract][Full Text] [Related]
31. Transfusion medicine and the pregnant patient.
Lee AI; Kaufman RM
Hematol Oncol Clin North Am; 2011 Apr; 25(2):393-413, ix. PubMed ID: 21444037
[TBL] [Abstract][Full Text] [Related]
32. Perinatal risk factors associated with severity of haemolytic disease of the foetus and newborn due to Rhc maternal-foetal incompatibility: A retrospective cohort study.
Franchinard L; Maisonneuve E; Friszer S; Toly Ndour C; Huguet-Jacquot S; Maurice P; Mailloux A; Cortey A; Jouannic JM
Vox Sang; 2022 Apr; 117(4):570-579. PubMed ID: 34743337
[TBL] [Abstract][Full Text] [Related]
33. Diagnosis and treatment of severe hemolytic disease of the fetus and newborn: a 10-year nationwide retrospective study.
Sainio S; Nupponen I; Kuosmanen M; Aitokallio-Tallberg A; Ekholm E; Halmesmäki E; Orden MR; Palo P; Raudaskoski T; Tekay A; Tuimala J; Uotila J; Stefanovic V
Acta Obstet Gynecol Scand; 2015 Apr; 94(4):383-90. PubMed ID: 25603954
[TBL] [Abstract][Full Text] [Related]
34. Hydrops fetalis with isolated massive ascites in a preterm neonate with rhesus disease.
Nourkami-Tutdibi N; Geipel M; Meyberg-Solomayer G; Takacs Z; Meyer S
Wien Med Wochenschr; 2022 Oct; 172(13-14):290-291. PubMed ID: 33738630
[TBL] [Abstract][Full Text] [Related]
35. Fatal hemolytic disease of the fetus and newborn caused by anti-Jr
Kim MS; Kim JS; Park H; Chung Y; Kim H; Ko DH; Hwang SH; Won HS; Oh HB
Transfus Apher Sci; 2020 Feb; 59(1):102605. PubMed ID: 31324575
[TBL] [Abstract][Full Text] [Related]
36. Immunological principle of development of red blood cell alloimmunization in pregnancy, hemolytic disease of the fetus and prevention of RhD alloimmunization in RhD negative women.
Roubalová L; Lubušký M
Ceska Gynekol; 2020; 85(6):408-416. PubMed ID: 33711901
[TBL] [Abstract][Full Text] [Related]
37. Erythrokinetic mechanism(s) causing the "late anemia" of hemolytic disease of the fetus and newborn.
Christensen RD; Bahr TM; Ohls RK; Ilstrup SJ; Moise KJ; Lopriore E; Meznarich JA
J Perinatol; 2024 Jun; 44(6):916-919. PubMed ID: 38216678
[TBL] [Abstract][Full Text] [Related]
38. Hemolytic Disease of the Fetus and Newborn Caused by Maternal Autoantibody with Mimicking Anti-E Specificity.
Chen X; Feng J; Jiang Y
Lab Med; 2021 Jul; 52(4):399-402. PubMed ID: 33219819
[TBL] [Abstract][Full Text] [Related]
39. Conservative Management of Hyperferritinemia in Hemolytic Disease of the Fetus and Newborn: A Case Report and Review of the Literature.
Adam DL; Bowes L; Goodyear L; Moorehead PC
J Pediatr Hematol Oncol; 2021 Mar; 43(2):73-76. PubMed ID: 31460887
[TBL] [Abstract][Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
